Sweden and Tanzania to Start HIV Vaccine Trials
September 17, 2004
Investigators will begin trials of an HIV vaccine in Sweden next month and plan to extend the program to Tanzania next year, Mohammed Bakari, a researcher at the Muhimbili University College of Health Sciences in Dar es Salaam, said today. The DNA-MVA vaccine will target HIV subtypes prevalent in Tanzania. The vaccine was developed under the HIV Vaccine Immunogencity Study, a European Union-funded partnership between Tanzania and Sweden.
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.